Delisting Determination,The Nasdaq Stock Market, LLC,
June 24, 2019, Insys Therapeutics, Inc. The Nasdaq
Stock Market, Inc. (the Exchange) has determined to remove
from listing the common stock of Insys Therapeutics, Inc.
(the Company), effective at the opening of the trading
session on July 5, 2019. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rules 5101, 5110(b), and IM-5101-1.
The Company was notified
of the Staffs determination on June 10, 2019.  The Company
did not appeal the Staff determination to the
Hearings Panel, and the Staff determination to delist the
Company became final on June 19, 2019.